Please ensure Javascript is enabled for purposes of website accessibility
홈 > 제품 > 항체 > 중화 항체

InVivoMAb Anti-Mouse TRANCE/TNFSF11/RANK L Antibody (7C6) (MT439010)

InVivoMAb Anti-Mouse TRANCE/TNFSF11/RANK L Antibody (7C6)
InVivoMAb Anti-Mouse TRANCE/TNFSF11/RANK L Antibody (7C6)
가격(USD):
사양:
  • 100ug
  • 1mg
수량:
문의하기
  • 개요

  • 이미지

  • 참고 문헌

  • 데이터시트

  • SDS

개요
카탈로그 번호MT439010
설명
InVivoMAb Anti-Mouse CD254/RANKL Antibody (7C6) [7C6] (MT439010) is a mouse monoclonal antibody detecting Tumor necrosis factor ligand superfamily member 11 in ELISA, Neutralization. Suitable for Mouse.
종 반응성Mouse
응용 분야ELISA, Neutralization
숙주 종Mouse
클론성Monoclonal
이소타입VHH-mFc
클론 ID7C6
타겟 Tumor necrosis factor ligand superfamily member 11, Osteoclast differentiation factor, ODF, Osteoprotegerin ligand, OPGL, Receptor activator of nuclear factor kappa-B ligand, RANKL, TNF-related activation-induced cytokine, TRANCE, CD254, Tumor necrosis factor ligand superfamily member 11, membrane form, Tumor necrosis factor ligand superfamily member 11, soluble form, Tnfsf11, Opgl, Rankl, Trance
내독소 수준 Please contact with the lab for this information.
순도 >95% as determined by SDS-PAGE.
관련 제품 pH 7.4 Dilution Buffer
정제 Protein A/G purified from cell culture supernatant.
등록번호 O35235
형태 Liquid
저장 완충액 0.01M PBS pH 7.4

데이터시트 인쇄본 또는 로트별 COA에 기재된 구체적인 완충액 정보를 참조하세요.

안정성 및 저장 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
배경

Tumor necrosis factor ligand superfamily member 11 (CD254/RANKL) is a ~35 kDa protein. Cytokine that binds to TNFRSF11B/OPG and to TNFRSF11A/RANK. Osteoclast differentiation and activation factor. Augments the ability of dendritic cells to stimulate naive T-cell proliferation. May be an important regulator of interactions between T-cells and dendritic cells and may play a role in the regulation of the T-cell-dependent immune response. May also play an important role in enhanced bone-resorption in humoral hypercalcemia of malignancy. CD254 is the therapeutic target of denosumab (Prolia).

1. Linares, GR. et al. (2012) Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 27, 1553-65. PMID: 22437732
2. Mahoney, DJ. et al. (2008) The Journal of biological chemistry 283, 25952-62. PMID: 18586671
3. Tiedemann, K. et al. (2013) Journal of cell science 126, 4187-94. PMID: 24039232
4. Omata, Y. et al. (2016) PloS one 11, e0157992. PMID: 27336669
5. Kim, H. et al. (2013) Cell metabolism 17, 249-60. PMID: 23395171
6. Decker, CE. et al. (2015) Proceedings of the National Academy of Sciences of the United States of America 112, 15654-9. PMID: 26644563
참고사항 For research use only. Not suitable for clinical or therapeutic use.
Isotype Control VHH mIgG2a Fc Recombinant Isotype Control Antibody (HyHEL-10) (MP167023)
이미지
  • InVivoMAb Anti-Mouse TRANCE/TNFSF11/RANK L Antibody (7C6)

    SDS-PAGE

    SDS-PAGE for InVivoMAb Anti-Mouse CD254/RANKL Antibody (7C6).

참고 문헌
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
추천

문의하기 맞춤형 견적, 대량 주문 및 기타 문의 사항은

메일: [email protected]

배급사 목록